Cargando…

The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases

PURPOSE: As an alternative to technetium-99m-macroaggregated albumin ((99m)Tc-MAA), a scout dose of holmium-166 ((166)Ho) microspheres can be used prior to (166)Ho-radioembolization. The use of identical particles for pre-treatment and treatment procedures may improve the predictive value of pre-tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Smits, Maarten L. J., Dassen, Mathijs G., Prince, Jip F., Braat, Arthur J. A. T., Beijst, Casper, Bruijnen, Rutger C. G., de Jong, Hugo W. A. M., Lam, Marnix G. E. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075844/
https://www.ncbi.nlm.nih.gov/pubmed/31399801
http://dx.doi.org/10.1007/s00259-019-04460-y
_version_ 1783507098563248128
author Smits, Maarten L. J.
Dassen, Mathijs G.
Prince, Jip F.
Braat, Arthur J. A. T.
Beijst, Casper
Bruijnen, Rutger C. G.
de Jong, Hugo W. A. M.
Lam, Marnix G. E. H.
author_facet Smits, Maarten L. J.
Dassen, Mathijs G.
Prince, Jip F.
Braat, Arthur J. A. T.
Beijst, Casper
Bruijnen, Rutger C. G.
de Jong, Hugo W. A. M.
Lam, Marnix G. E. H.
author_sort Smits, Maarten L. J.
collection PubMed
description PURPOSE: As an alternative to technetium-99m-macroaggregated albumin ((99m)Tc-MAA), a scout dose of holmium-166 ((166)Ho) microspheres can be used prior to (166)Ho-radioembolization. The use of identical particles for pre-treatment and treatment procedures may improve the predictive value of pre-treatment analysis of distribution. The aim of this study was to analyze the agreement between (166)Ho-scout and (166)Ho-therapeutic dose in comparison with the agreement between (99m)Tc-MAA and (166)Ho-therapeutic dose. METHODS: Two separate scout dose procedures were performed ((99m)Tc-MAA and (166)Ho-scout) before treatment in 53 patients. First, qualitative assessment was performed by two blinded nuclear medicine physicians who visually rated the agreement between the (99m)Tc-MAA, (166)Ho-scout, and (166)Ho-therapeutic dose SPECT-scans (i.e., all performed in the same patient) on a 5-point scale. Second, agreement was measured quantitatively by delineating lesions and normal liver on FDG-PET/CT. These volumes of interest (VOIs) were co-registered to the SPECT/CT images. The predicted absorbed doses (based on (99m)Tc-MAA and (166)Ho-scout) were compared with the actual absorbed dose on post-treatment SPECT. RESULTS: A total of 23 procedures (71 lesions, 22 patients) were included for analysis. In the qualitative analysis, (166)Ho-scout was superior with a median score of 4 vs. 2.5 for (99m)Tc-MAA (p < 0.001). The quantitative analysis showed significantly narrower 95%-limits of agreement for (166)Ho-scout in comparison with (99m)Tc-MAA when evaluating lesion absorbed dose (− 90.3 and 105.3 Gy vs. − 164.1 and 197.0 Gy, respectively). Evaluation of normal liver absorbed dose did not show difference in agreement between both scout doses and (166)Ho-therapeutic dose (− 2.9 and 5.5 Gy vs − 3.6 and 4.1 Gy for (99m)Tc-MAA and (166)Ho-scout, respectively). CONCLUSIONS: In this study, (166)Ho-scout was shown to have a superior predictive value for intrahepatic distribution in comparison with (99m)Tc-MAA.
format Online
Article
Text
id pubmed-7075844
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-70758442020-03-23 The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases Smits, Maarten L. J. Dassen, Mathijs G. Prince, Jip F. Braat, Arthur J. A. T. Beijst, Casper Bruijnen, Rutger C. G. de Jong, Hugo W. A. M. Lam, Marnix G. E. H. Eur J Nucl Med Mol Imaging Original Article PURPOSE: As an alternative to technetium-99m-macroaggregated albumin ((99m)Tc-MAA), a scout dose of holmium-166 ((166)Ho) microspheres can be used prior to (166)Ho-radioembolization. The use of identical particles for pre-treatment and treatment procedures may improve the predictive value of pre-treatment analysis of distribution. The aim of this study was to analyze the agreement between (166)Ho-scout and (166)Ho-therapeutic dose in comparison with the agreement between (99m)Tc-MAA and (166)Ho-therapeutic dose. METHODS: Two separate scout dose procedures were performed ((99m)Tc-MAA and (166)Ho-scout) before treatment in 53 patients. First, qualitative assessment was performed by two blinded nuclear medicine physicians who visually rated the agreement between the (99m)Tc-MAA, (166)Ho-scout, and (166)Ho-therapeutic dose SPECT-scans (i.e., all performed in the same patient) on a 5-point scale. Second, agreement was measured quantitatively by delineating lesions and normal liver on FDG-PET/CT. These volumes of interest (VOIs) were co-registered to the SPECT/CT images. The predicted absorbed doses (based on (99m)Tc-MAA and (166)Ho-scout) were compared with the actual absorbed dose on post-treatment SPECT. RESULTS: A total of 23 procedures (71 lesions, 22 patients) were included for analysis. In the qualitative analysis, (166)Ho-scout was superior with a median score of 4 vs. 2.5 for (99m)Tc-MAA (p < 0.001). The quantitative analysis showed significantly narrower 95%-limits of agreement for (166)Ho-scout in comparison with (99m)Tc-MAA when evaluating lesion absorbed dose (− 90.3 and 105.3 Gy vs. − 164.1 and 197.0 Gy, respectively). Evaluation of normal liver absorbed dose did not show difference in agreement between both scout doses and (166)Ho-therapeutic dose (− 2.9 and 5.5 Gy vs − 3.6 and 4.1 Gy for (99m)Tc-MAA and (166)Ho-scout, respectively). CONCLUSIONS: In this study, (166)Ho-scout was shown to have a superior predictive value for intrahepatic distribution in comparison with (99m)Tc-MAA. Springer Berlin Heidelberg 2019-08-09 2020 /pmc/articles/PMC7075844/ /pubmed/31399801 http://dx.doi.org/10.1007/s00259-019-04460-y Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Smits, Maarten L. J.
Dassen, Mathijs G.
Prince, Jip F.
Braat, Arthur J. A. T.
Beijst, Casper
Bruijnen, Rutger C. G.
de Jong, Hugo W. A. M.
Lam, Marnix G. E. H.
The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
title The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
title_full The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
title_fullStr The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
title_full_unstemmed The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
title_short The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
title_sort superior predictive value of (166)ho-scout compared with (99m)tc-macroaggregated albumin prior to (166)ho-microspheres radioembolization in patients with liver metastases
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075844/
https://www.ncbi.nlm.nih.gov/pubmed/31399801
http://dx.doi.org/10.1007/s00259-019-04460-y
work_keys_str_mv AT smitsmaartenlj thesuperiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT dassenmathijsg thesuperiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT princejipf thesuperiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT braatarthurjat thesuperiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT beijstcasper thesuperiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT bruijnenrutgercg thesuperiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT dejonghugowam thesuperiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT lammarnixgeh thesuperiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT smitsmaartenlj superiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT dassenmathijsg superiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT princejipf superiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT braatarthurjat superiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT beijstcasper superiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT bruijnenrutgercg superiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT dejonghugowam superiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases
AT lammarnixgeh superiorpredictivevalueof166hoscoutcomparedwith99mtcmacroaggregatedalbuminpriorto166homicrospheresradioembolizationinpatientswithlivermetastases